| Bioactivity | Bischloroanthrabenzoxocinone is a potent Type II fatty acid synthesis (FASII) inhibitor. Bischloroanthrabenzoxocinone inhibits fatty acid synthesis. Bischloroanthrabenzoxocinone shows antibacterial activities and inhibits phospholipid, DNA, RNA, protein, and cell wall synthesis[1]. |
| Invitro | Bischloroanthrabenzoxocinone (0.01-333 µg/mL) 抑制脂肪酸合成,对 Staphylococcus aureus 和 Escherichia coli 的 IC50 值分别为 11.4、35.3 µg/mL[1].Bischloroanthrabenzoxocinone (0-250 µg/mL) 显示出抗菌活性,对 Staphylococcus aureus 和 野生型 Escherichia coli 的 MIC 值分别为 0.2、>250 µg/mL [1].Iscloroanthrabenzoxocinone 抑制磷脂合成,IC50 值为 0.21 μg/ml,它还抑制 Staphylococcus aureus 和 Escherichia coli 中的 DNA、RNA、蛋白质和细胞壁合成[1]。 |
| Name | Bischloroanthrabenzoxocinone |
| CAS | 866022-28-8 |
| Formula | C28H24Cl2O7 |
| Molar Mass | 543.39 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kodali S, et al. Determination of selectivity and efficacy of fatty acid synthesis inhibitors. J Biol Chem. 2005 Jan 14;280(2):1669-77. |